Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Extel 2010

16 Jun 2010 09:19

RNS Number : 6983N
Arden Partners plc
16 June 2010
 



Arden Partners plc

("Arden" or the "Company")

Arden Partners, the institutional stockbroker, is delighted that its equity brokerage and research teams ranked highly in Extel's 2010 UK Survey. 

Fund managers voted Arden No. 1 for broking Financials (Jeremy Grime, Sarah Spikes, Peter Lenardos) and No. 3 for broking Capital Goods (Ben Thefaut, Chris Thomas, David Larkam, and Graham Webster).

Individually, Jeremy Grime and Sarah Spikes were voted the No. 1 and No. 2 analysts in Financials.

Extel 2010 is based on record participation across the professional investment community, with data and processes independently verified by Deloitte.

Commenting on the result, Jonathan Keeling, CEO of Arden said;

"We are delighted that our teams and individuals have been recognised by the buy-side community at these awards. We have a strong capability in our research department across our specialist sectors and these awards demonstrate our commitment to recruiting and retaining quality analysts and salespeople to provide leading insightful analysis."

For further information, please contact:

 

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

 

Buchanan Communications 020 7466 5000

Mark Edwards / Nicola Cronk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUBGQUPUURQ
Date   Source Headline
11th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
11th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
10th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
10th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
4th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
1st Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
29th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
29th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
26th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
13th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
13th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
12th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
8th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
8th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
7th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
6th Jul 201111:57 amRNSAdditional Listing
6th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
5th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
5th Jul 20117:00 amRNSInterim results
4th Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 201111:50 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
27th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
23rd Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
22nd Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
21st Jun 201112:18 pmRNSForm 8.5 (EPT/NON-RI)
17th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
14th Jun 201111:52 amRNSForm 8.5 (EPT/NON-RI)
14th Jun 20117:00 amRNSAppointment of Chairman
13th Jun 201112:31 pmRNSForm 8.5 (EPT/NON-RI)
8th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 201111:50 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 20113:15 pmRNSBlocklisting Interim Review
6th Jun 201111:54 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.